275
Participants
Start Date
May 1, 2017
Primary Completion Date
April 30, 2025
Study Completion Date
April 30, 2025
Neuropsychological Assessment
Assessments include: Paper and pencil computerized measures of Memory, Language, Visuospatial Function, Executive Functioning-Processing Speed, and Attention
Spirometry
Pre and post bronchodilator spirometry will be administered according to the American Thoracic Society (ATS) guidelines.
Arterial Blood Gas
Radial artery blood sample will be collected to measure gas exchange hemoglobin; arterial oxygen and carbon dioxide will be examined as potential covariates.
Diffusion Capacity of the Lung for Carbon Monoxide
For measurement of gas exchange in the lung. DLCO adjusted for hemoglobin will be the primary variable of interest and will be examined as a potential covariate.
6 Minute Walk Test
Distance walked in 6 minutes will be the primary outcome.
Systemic Vascular Measures
Carotid artery ultrasound, pulse wave velocity, brachial artery endothelium-dependent flow mediated dilation and endothelium-independent dilation will be measured.
Blood Biomarkers
High sensitivity C-reactive protein (hs-CRP), and fibrinogen will be used as indicators of systemic inflammation, complete blood count with differential (CBC with diff) will be obtained to rule out acute infection as a cause of inflammation.
Symptom Questionnaire Measures
M.I.N.I Screen 7.0.0, Beck Depression Inventory-II (DBI-II), State Trait Anxiety Inventory (STAI), COPD Assessment Test (CAT), St. George's Respiratory Questionnaire (SGRQ), MMRC Dyspnea Scale (MMRC), Berlin Questionnaire
Brain MRI
Primary neuroimaging outcomes of interest are white matter structural integrity
RECRUITING
Carinda Linkenmeyer, Iowa City
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Institutes of Health (NIH)
NIH
Karin Hoth
OTHER